Back to Trades
Total Value
$1.4M
Net $1.4M bought
Filing Date
Jul 20, 2026
2 transactions
Purchases
$1.4M
2 transactions
Trade Summary
On Jul 16, 2026 through Jul 17, 2026, RA CAPITAL MANAGEMENT, L.P., Insider, purchased $1.4M of Artiva Biotherapeutics, Inc. (ARTV) across 2 transactions. The filing covers Common Stock and reflects net buying of $1.4M. Reported prices ranged from $8.93 to $8.95. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- Artiva Biotherapeutics, Inc.
- Ticker Symbol
- ARTV
- CIK
- 0001817241
Insider Information
- Role
- Insider
- Location
- BOSTON, MA
Filing Details
- Filing Date
- Jul 20, 2026
- Transaction Date
- Jul 16, 2026
- Accession Number
- 0001231919-26-000774
- Form Type
- 4
- Net Trading Amount
- $1.4M
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Jul 16, 2026 | Common Stock | 152,472 | $8.93 | Purchase | $1.4M |
| Jul 17, 2026 | Common Stock | 7,882 | $8.95 | Purchase | $70.5K |
Want live alerts when RA CAPITAL MANAGEMENT, L.P. trades again?
Download Insider Trades to track ARTV, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.79 to $9.00 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- (F2)RA Capital Management, L.P. (the "Adviser") is the investment manager for RA Capital Healthcare Fund, L.P. (the "Fund"), RA Capital Nexus Fund, L.P. (the "Nexus Fund"), RA Capital Nexus III Fund, L.P. (the "Nexus Fund III"), and a separately managed account (the "Account"). The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. The Adviser, the Adviser GP, the Fund, the Nexus Fund, the Nexus Fund III, Dr. Kolchinsky and Mr. Shah disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein.
- (F3)Held directly by the Fund.
- (F4)The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.88 to $9.00 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- (F5)Held directly by the Nexus Fund.
- (F6)Held directly by Nexus Fund III.
- (F7)Held directly by the Account.